Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Michael H. Davidson

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Davidson, Michael H.

Item TypeName
Concept Indoles
Academic Article Statin trials in progress: unanswered questions.
Academic Article The cost of reaching National Cholesterol Education Program (NCEP) goals in hypercholesterolaemic patients. A comparison of atorvastatin, simvastatin, lovastatin and fluvastatin.
Academic Article A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d.
Academic Article Extended-release niacin/laropiprant: reducing niacin-induced flushing to better realize the benefit of niacin in improving cardiovascular risk factors.
Academic Article Novel nonstatin strategies to lower low-density lipoprotein cholesterol.
Academic Article Considerations in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation.
Academic Article Flushing profile of extended-release niacin/laropiprant versus gradually titrated niacin extended-release in patients with dyslipidemia with and without ischemic cardiovascular disease.
Academic Article Fluvastatin administration at bedtime versus with the evening meal: a multicenter comparison of bioavailability, safety, and efficacy.
Academic Article Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia.
Academic Article Fluvastatin Long-Term Extension Trial (FLUENT): summary of efficacy and safety.
Academic Article Lipid-altering efficacy and safety profile of co-administered extended release niacin/laropiprant and simvastatin versus atorvastatin in patients with mixed hyperlipidemia.
Academic Article Cognitive Effects of MIN-101 in Patients With Schizophrenia and Negative Symptoms: Results From a Randomized Controlled Trial.
Academic Article Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia.
Academic Article Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trial.
Academic Article The brief negative symptom scale (BNSS): Sensitivity to treatment effects.

Search Criteria
  • Indoles